Oncotarget has managed to leverage the use of peer-review to influence their research impact to the optimum positively. It has significantly increased the number of its publication to meet the high demand for its products. Oncotarget is publishing two issues per week due to its positive impact on the society. The issues are of higher quality, bigger volume. To spread the significant scientific information, all papers accepted are forming part of the final paginated issues which are always given to PubMed in their permanent form. The submission of two issues per week will ensure that there are no delays at all in the future and learn more about Oncotarget.
Oncotarget is very prominent since its very clear to understand, helpful, timely and well peer-reviewed. Oncotarget accepts and publishes papers which cover not only the oncology but also cell biology, pharmacology, endocrinology, cardiology, metabolism and neuroscience among others. It was ranked number one 2015-2016 among all the journals about oncology. Oncotarget comprehensively covers all molecules, cellular functions and pathways always found in neurodegeneration and atherosclerosis, cancer and aging, cancer cells and microbes, lymphocytes and neurons. It is a traditional journal which is composed of various disciplines with free access. The main mission of the Oncotarget is to increase the rate at which the scientific information is disseminated and to make it available widely. To allow faster dissemination of exceptional discoveries, to break the barrier between different specialties and connect various fields of biomedical science. Oncotarget also promotes applications of basic and clinical to battle against the disease and read full aritcle.
Through the leadership of qualified and experienced scientists, the journal enables researchers from different parts of the world to contribute to the progress and development of science. The Oncortaget ultimate aim is to have the world with no disease, a life without sickness. Oncotarget is a weekly journal, peer-reviewed with different scientists, and it can be accessed freely, a medical journal which covers research on all different aspects of oncology. The journal became operational from 2010, published by impact journal. The editors-in-chief are Andrei V. Gudkov and Mikhail Blagosklonny. The success of the Oncotarget has encouraged them to publish papers beyond oncology and more information click here.
More Visit: http://www.bioxbio.com/if/html/ONCOTARGET.html